文献速递主动脉疾病

无症状腹主动脉瘤的腔内修复与开放修复比较:一项12年回顾性队列分析

Endovascular Versus Open Repair for Asymptomatic Abdominal Aortic Aneurysms: A 12-Year Retrospective Cohort Analysis.
PubMed 文献 · Ann Vasc Surg · 2024-12-26

本研究回顾性比较无症状腹主动脉瘤患者接受腔内修复(EVAR)与开放修复(OAR)的早期和晚期结局,纳入564例患者(EVAR 445例,OAR 119例),时间跨度为2010年1月至2022年1月。事后非劣效性分析提示EVAR在30天死亡率方面非劣于OAR(差异-2.47%,95%CI:-0.5%至5.4%,P=0.005),EVAR围手术期指标更优但晚期动脉瘤相关并发症更多,OAR晚期剖腹相关并发症更多。作者认为这些发现支持EVAR作为有价值的选择,尤其对高风险患者,同时强调需要针对术式的长期监测,并指出需要未来前瞻性研究确认这些事后分析结果。

要点

  • EVAR组30天死亡率为0.9%,OAR组为3.4%,事后非劣效性分析提示EVAR非劣于OAR。
  • EVAR组手术时间、失血量和住院时间均优于OAR组,早期再次干预率更低(1.3% vs 8.4%)。
  • EVAR组晚期动脉瘤相关并发症更多(16.9% vs 5.0%),OAR组晚期剖腹相关并发症更多(8.4% vs 0.2%)。

核心结论

  • 事后非劣效性分析提示,对于无症状腹主动脉瘤患者,EVAR在30天死亡率方面非劣于OAR。
  • EVAR显示出围手术期获益和更少的早期并发症,但两种术式的长期并发症谱不同。
  • 这些发现支持EVAR作为有价值的选择,尤其对高风险患者,同时强调需要针对术式的长期监测。
  • 需要未来前瞻性研究来确认这些事后分析结果。

研究设计与样本

  • 回顾性观察性队列研究,纳入2010年1月至2022年1月期间接受腹主动脉瘤修复的无症状患者564例(EVAR 445例,OAR 119例)。
  • 主要结局包括30天死亡率和院内死亡率;次要结局包括手术细节、住院时间、并发症和长期生存。
  • 对30天死亡率进行了事后非劣效性分析,非劣效性界值为1%。

主要发现

  • EVAR组患者年龄更大(75.6 ± 7.7岁 vs 68.7 ± 9.5岁,P < 0.001),且更多被评估为不适合开放修复(53.0% vs 10.1%,P < 0.001)。
  • EVAR组手术时间更短(149.5 ± 70.8分钟 vs 303.5 ± 115.7分钟,P < 0.001),失血量更少(中位数200 mL vs 1,500 mL,P < 0.001),住院时间更短(中位数5天 vs 9天,P < 0.001)。
  • 30天死亡率EVAR组为0.9%,OAR组为3.4%;事后非劣效性分析提示EVAR非劣于OAR(差异-2.47%,95%CI:-0.5%至5.4%,P = 0.005)。
  • EVAR组早期再次干预显著更少(1.3% vs 8.4%,P < 0.001);EVAR组早期剖腹相关并发症显著更少(0.2% vs 5.0%,P < 0.001),但晚期动脉瘤相关并发症更多(16.9% vs 5.0%,P = 0.002);OAR组晚期剖腹相关并发症更多(8.4% vs 0.2%,P < 0.0001)。
  • 两组晚期并发症合计发生率无显著差异(17.1% vs 13.4%,P = 0.314);EVAR组5年生存率较低,可能由于老年和不适合手术患者比例更高。

关键数值与推荐

  • 30天死亡率非劣效性分析:差异-2.47%,95%CI:-0.5%至5.4%,P = 0.005,非劣效性界值为1%。
  • EVAR组30天死亡率为0.9%,OAR组为3.4%。
  • EVAR组早期再次干预率为1.3%,OAR组为8.4%(P < 0.001)。
  • EVAR组晚期动脉瘤相关并发症发生率为16.9%,OAR组为5.0%(P = 0.002);OAR组晚期剖腹相关并发症发生率为8.4%,EVAR组为0.2%(P < 0.0001)。
  • 两组晚期并发症合计发生率:EVAR组17.1% vs OAR组13.4%(P = 0.314),无显著差异。

临床怎么用

  • 作者认为这些发现支持EVAR作为有价值的选择,尤其对高风险患者。
  • 作者强调需要针对术式的长期监测。
  • 作者指出需要未来前瞻性研究来确认这些事后分析结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aneurysm repair (EVAR) has become increasingly prevalent for treating asymptomatic abdominal aortic aneurysms (AAAs). This study compares the early and late outcomes between EVAR and open aneurysm repair (OAR) in asymptomatic AAA patients. METHODS: A retrospective observational cohort study was conducted involving 564 patients (445 EVAR and 119 OAR) who underwent AAA repair from January 2010 to January 2022. Primary outcomes included 30-day and in-hospital mortality. Secondary outcomes encompassed operative details, hospital stay, complications, and long-term survival. A post-hoc noninferiority analysis for 30-day mortality was performed with a noninferiority margin of 1%. RESULTS: EVAR patients were older (75.6 ± 7.7 vs. 68.7 ± 9.5 years, P < 0.001) and more often deemed unfit for open repair (53.0% vs. 10.1%, P < 0.001). EVAR demonstrated advantages in operative time (149.5 ± 70.8 vs. 303.5 ± 115.7 minutes, P < 0.001), blood loss (median 200 vs. 1,500 mL, P < 0.001), and hospital stay (median 5 vs. 9 days, P < 0.001). Thirty-day mortality was 0.9% for EVAR and 3.4% for OAR. Post-hoc noninferiority analysis suggested EVAR was noninferior to OAR for 30-day mortality (difference -2.47%, 95% confidence interval: -0.5% to 5.4%, P = 0.005). EVAR had significantly fewer early reinterventions (1.3% vs. 8.4%, P < 0.001). Detailed complication analysis revealed that EVAR had significantly fewer early laparotomy-related complications (0.2% vs. 5.0%, P < 0.001) but more late aneurysm-related complications (16.9% vs. 5.0%, P = 0.002). Conversely, OAR had more late laparotomy-related complications (8.4% vs. 0.2%, P < 0.0001). The combined rate of late complications was not significantly different between groups (17.1% vs. 13.4%, P = 0.314). The EVAR group exhibited lower 5-year survival, likely due to the higher proportion of elderly and unfit patients. CONCLUSIONS: The post-hoc noninferiority analysis suggests that EVAR is noninferior to OAR in terms of 30-day mortality for asymptomatic AAA patients. EVAR demonstrated perioperative benefits and fewer early complications, while long-term complication profiles differed between procedures. These findings support EVAR as a valuable option, particularly for higher-risk patients, while highlighting the need for procedure-specific long-term surveillance. Future prospective studies are needed to confirm these post-hoc findings.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chinsakchai K, Thorthititum D, Hongku K, et al. Endovascular Versus Open Repair for Asymptomatic Abdominal Aortic Aneurysms: A 12-Year Retrospective Cohort Analysis. Ann Vasc Surg. 2024. PMID: 39732329. doi:10.1016/j.avsg.2024.12.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。